Early Relapse after Autologous Hematopoietic Cell Transplantation remains a Poor Prognostic Factor in Multiple Myeloma but Outcomes Have Improved Over Time

Duration of initial disease response remains a strong prognostic factor in multiple myeloma (MM) particularly for upfront autologous hematopoietic cell transplant (AHCT) recipients. We hypothesized that new drug classes and combinations employed prior to AHCT as well as after post-AHCT relapse may h...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Leukemia
Hauptverfasser: Kumar, Shaji K, Dispenzieri, Angela, Fraser, Raphael, Mingwei, Fei, Akpek, Gorgun, Cornell, Robert, Kharfan-Dabaja, Mohamed, Freytes, Cesar, Hashmi, Shahrukh, Hildebrandt, Gerhard, Holmberg, Leona, Kyle, Robert, Lazarus, Hillard, Lee, Cindy, Mikhael, Joseph, Nishihori, Taiga, Tay, Jason, Usmani, Saad, Vesole, David, Vij, Ravi, Wirk, Baldeep, Krishnan, Amrita, Gasparetto, Cristina, Mark, Tomer, Nieto, Yago, Hari, Parameswaran, D’Souza, Anita
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2017
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5871538/
https://ncbi.nlm.nih.gov/pubmed/29263438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2017.331
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge